Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 2/20 | 0.42 |
| ▸ | GSK3B | P49841 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1574229 | 0.90 | CYP11B2 (0.33) | ALDH1A1MAPK1 | |
| SCHEMBL9120305 | 0.73 | ALDH1A1 (0.40) | GSK3AGSK3BALDH1A1MAPK1SMN1; SMN2 | |
| SCHEMBL6926598 | 0.70 | CCNE1 (0.41) | GSK3AGSK3BALDH1A1CCNE1CDK2 | |
| SCHEMBL19309154 | 0.68 | PDE1C (0.44) | KMT2A | |
| SCHEMBL4226383 | 0.67 | SLC18A3 (0.32) | ALDH1A1SMN1; SMN2CYP2C9CYP3A4KMT2A | |
| Carbon Monoxide SCHEMBL8152719 | 0.67 | ALDH1A1 (0.34) | ALDH1A1SMN1; SMN2CYP2C9CYP3A4KMT2A | |
| SCHEMBL27339559 | 0.67 | LPO (0.44) | GSK3AGSK3BCYP2C9CYP2C19KDM4E | |
| SCHEMBL2195541 | 0.66 | — | — | |
| SCHEMBL2194989 | 0.66 | — | — | |
| SCHEMBL27831183 | 0.66 | POLB (0.38) | ALDH1A1MAPK1SMN1; SMN2CYP2C9CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10245559-B2 | Nanofiltration membranes and methods of use | NOVOMER, INC. (US) | 2019-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10245559-B2 | Nanofiltration membranes and methods of use | MLEC, EPCAM, LNPK | GSK3A 4470/4885GSK3B 4578/4885ALDH1A1 1130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.